Injectable Drug Delivery Market by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Global Forecasts to 2017

世界の注入型ドラッグデリバリー(薬物送達)市場

◆タイトル:Injectable Drug Delivery Market by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Global Forecasts to 2017
◆商品コード:BT 1862
◆調査・発行会社:MarketsandMarkets
◆発行日:2013年4月
◆ページ数:368
◆レポート形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single userUSD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User(~5名まで)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate licence(社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"世界の注入型ドラッグデリバリー(薬物送達)市場"について調査・分析し、イントロダクション、エグゼクティブサマリー、市場概観、市場の成長要因、阻害要因、市場の機会と課題、市場の動態、地域別分析、市場規模及び予測、競争状況、市場シェア分析、新製品発売、主要企業(ベンダー)分析等の情報をお届けいたします。

The global injectable drug delivery technologies market was valued at $22.5 billion in 2012, and is expected to reach $43.3 billion by 2017 at a CAGR of 14.0% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The global injectable drug delivery formulations technologies market was the largest segment in this market. This is due to surge of biologics and development of nanotechnologies. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices.

The growth of the injectable drug delivery technologies market is primarily triggered by product life cycle management, technological advancements, surge of biologics in pharmaceutical markets, rising incidences of cancer and diabetes at global level and improving patient compliance. The evolving opportunities in this market for manufacturers include development of biosimilars in pharmaceutical markets and focus of pharmaceutical manufacturers towards emerging markets such as, India, and China. However, factors such as needle-stick injuries and infections, development of alternate delivery methods and product recalls are restraining the growth of the market.

North America accounted for the largest market share of 41.3% of the global injectable drug delivery technologies market, followed by Europe (30.2%) in 2012. However, the region lags behind Europe in the self injection devices market. This is owing to low penetration rate of pen injectors in the U.S. Asian and Latin American countries represent the fastest growing markets due to growing number of cancer and diabetes incidences, and improving patent compliance. Furthermore, stringent regulatory policies for approval of medical devices, and high competition in mature countries will compel the companies to focus on the emerging markets in Latin America and Asia.

Scope of the Report

This research report categorizes the global injectable drug delivery technologies marketinto two segments, namely, global injectable drug delivery devices technologies and global injectable drug delivery formulations technologies. These markets are broken down into segments and sub-segments, providing value analysis for 2010, 2011, and 2012, as well as forecast up to 2017. Each market is comprehensively analyzed by geography (North America, Europe, Asia-Pacific, and Rest of the World) to provide in-depth information on the global scenario.

Global Injectable Drug Delivery Technologies Market, By Segment

Injectable Drug Delivery Devices Technologies
Injectable Drug Delivery Formulations Technologies
Global Injectable Drug Delivery Devices TechnologiesMarket, By Product

Conventional Injection Devices
By Material
Glass
Plastics
By Product
Fillable Syringes
Prefilled Syringes
By Usability
Reusable
Disposable
Self-Injection Devices
Needle Free Injectors
By Product
Fillable Syringes
Prefilled Syringes
By Technology
Jet Based Needle Free Injectors
Spring Based Needle Free Injectors
Laser Powered Needle Free Injectors
Others
By Usability
Reusable
Disposable
Auto Injectors
By Products
Fillable Syringes
Prefilled Syringes
By Technology
Manual Injection Auto Injectors
Automated Injection Auto Injectors
By Design
Standardized Auto Injectors
Customized Auto Injectors
By Usability
Reusable
Disposable
Pen Injectors
By Products
Single Chambered Pen Injectors
Dual Chambered Pen Injectors
By design
Standardized pen injectors
Customized pen injectors
By usability
Reusable
Disposable
Others
Global Injectable Drug Delivery Formulations TechnologiesMarket, By Product

Conventional Drug Delivery Formulations
Solution
Reconstituted / Lyophilized Formulations
Novel Drug Delivery Formulations
Liposomal Systems
Microspheres
Nanoparticles
Polymeric Micelles
Others
Global Injectable Drug Delivery TechnologiesMarket, By TherapeuticApplications

Auto Immune Diseases
Multiple Sclerosis
Rheumatoid Arthritis
Crohn’s Diseases
Psoriasis
Others
Hormonal Disorders
Diabetes
Antithrombotic / Thrombolytic Therapy
Reproductive Health Diseases
Anemia
Osteoporosis
Others
Orphan Diseases
Oncology
Others
Pain Management
Allergies
Hepatitis C
Aesthetic Treatment
Injectable Drug Delivery Technologies Market, By Geography

North America
Europe
Asia-Pacific
RoW

【レポートの目次】

Table Of Contents

1 Introduction (Page No. – 26)
1.1 Key Take-Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
1.5.5 Assumptions

2 Executive Summary (Page No. – 34)

3 Market Overview (Page No. – 39)
3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Technological Advancements
3.3.1.2 Favorable Reimbursement Environment To Bolster The Demand Of Self Injection Devices
3.3.1.3 Surge Of Biologics In European Pharmaceutical Market
3.3.1.4 Rising Incidences Of Cancer And Diabetes
3.3.1.5 Improving Patient Compliance
3.3.2 Restraints
3.3.2.1 Needle-Stick Injuries And Infections
3.3.2.2 Threat From Alternate Drug Delivery Methods
3.3.2.3 Slow Approval Process Of Drugs And Medical Devices In Europe
3.3.3 Opportunities
3.3.3.1 Development Of Biosimilars In The European Pharmaceutical Market
3.3.3.2 Need For Better Healthcare For The Increasing Geriatric Population Of Europe
3.3.4 Challenges
3.3.4.1 Sustainability Of Players In Highly Competitive Market
3.4 Market Share Analysis, By Major Players
3.4.1 Conventional Injectable Drug Delivery Devices
3.4.2 Self-Injection Devices-Pen Injectors

4 European Injectable Drug Delivery Devices Technologies Market (Page No. – 65)
4.1 Introduction
4.2 Market Segmentation
4.3 Manufacturers Criteria For Selection Of An Injectable Device
4.4 Conventional Injectable Drug Delvery Devices
4.4.1 By Usability
4.4.1.1 Disposable
4.4.1.2 Reusable
4.4.2 By Material
4.4.2.1 Glass
4.4.2.2 Plastic
4.4.3 By Product
4.4.3.1 Fillable
4.4.3.2 Prefilled
4.5 Self-Injection Devices
4.5.1 Market Segmentation
4.5.2 Selection Criteria For Self-Injection Device
4.5.3 Pen Injectors
4.5.3.1 By Product
4.5.3.1.1 Single Chamber Pen Injectors
4.5.3.1.2 Dual Chamber Pen Injectors
4.5.3.2 By Usability
4.5.3.2.1 Disposable Pen Injectors
4.5.3.2.2 Reusable Pen Injectors
4.5.3.3 By Design
4.5.3.3.1 Standard Pen Injectors
4.5.3.3.2 Customized Pen Injectors
4.5.4 Needle-Free Injectors
4.5.4.1 By Product
4.5.4.1.1 Prefilled Needle Free Injectors
4.5.4.1.2 Fillable Needle Free Injectors
4.5.4.2 By Technology
4.5.4.2.1 Jet-Based Needle-Free Injectors
4.5.4.2.2 Spring-Based Needle-Free Injectors
4.5.4.2.3 Laser-Based Needle Free Injectors
4.5.4.2.4 Vibration-Based Needle Free Injectors
4.5.4.3 By Usability
4.5.4.3.1 Disposable
4.5.4.3.2 Reusable
4.5.5 Auto Injectors
4.5.5.1 By Product
4.5.5.1.1 Prefilled Auto Injectors
4.5.5.1.2 Fillable Auto Injectors
4.5.5.2 By Technology
4.5.5.2.1 Automated Auto Injectors
4.5.5.2.2 Manual Auto Injectors
4.5.5.3 By Design
4.5.5.3.1 Standardized Auto Injectors
4.5.5.3.2 Customized Auto Injectors
4.5.5.4 By Usability
4.5.5.4.1 Disposable Auto Injectors
4.5.5.4.2 Reusable Auto Injectors
4.6 Others

5 European Injectable Drug Delivery Formulation Technologies Market (Page No. – 141)
5.1 Introduction
5.2 Conventional Drug Delivery
5.2.1 Injectable Solutions
5.2.2 Reconstituted/Lyophilized Formulations
5.3 Novel Drug Delivery Formulation Technologies
5.3.1 Market Segmentation
5.3.2 Liposomal Systems
5.3.3 Microspheres
5.3.4 Nanoparticles
5.3.5 Polymeric Micelles
5.3.6 Others

6 European Injectable Drug Delivery Technologies Market, By Therapeutic Applications (Page No. – 168)
6.1 Introduction
6.2 Auto-Immune Diseases
6.2.1 Multiple Sclerosis
6.2.2 Rheumatoid Arthritis
6.2.3 Crohn’s Diseases
6.2.4 Psoriasis
6.2.5 Others
6.3 Hormonal Disorders
6.3.1 Diabetes
6.3.2 Anemia
6.3.3 Reproductive Health Diseases
6.3.4 Antithrombotic/Thrombolytic Therapy
6.3.5 Osteoporosis
6.3.6 Growth Hormone Deficiency
6.4 Orphan/Rare Diseases
6.5 Oncology
6.6 Others
6.6.1 Pain Management
6.6.2 Hepatitis C
6.6.3 Allergies
6.6.4 Aesthetic Treatment

7 Geographic Analysis (Page No. – 215)
7.1 Introduction
7.2 Germany
7.2.1 More Than 25 New Medicines Are Due For Marketing License In Germany For The Year 2013
7.3 France
7.3.1 Higher Insurance Coverage, Increase In Aging Population And Affordability Drives The Market In France
7.4 U.K.
7.4.1 Highest Turnover Of Antibiotics And Small Molecules Due To Oncology And Infections
7.4.2 Bioscience & Health Technology Database Provide Better Industry Data On Injectable Technologies
7.5 Spain
7.5.1 Spain Is Amongst The Top 10 Countries With Highest Expenditure On Diabetes
7.6 Italy
7.6.1 Removal Of Linkages Between Patent And Generic Medicines Causes Rapid Access To Generics In Italy
7.7 Russia
7.7.1 Russian Government Aimed To Foster The Development Of Healthcare System
7.8 Rest Of Europe
7.8.1 Switzerland Has The Most Competitive Economy And Has Leading Position In Global Pharmaceuticals And Biotech Industries
7.8.2 Denmark Provides For Concentrated Patient Pool Especially For Diabetes Due To Centralization Of Healthcare System
7.8.3 High Acceptability For New Technologies And Lowest Corporate Tax Rate Drives The Ireland Market
7.8.4 Favorable Growth In Regions Of Portugal, Poland, And Romania Due To Increasing Diabetes Incidence And Related Reimbursement Policies

8 Competitive Landscape (Page No. – 251)
8.1 Introduction
8.2 Expansion
8.3 Agreements, Partnerships, Collaborations & Joint Ventures
8.4 New Product Launch
8.5 Mergers & Acquisitions
8.6 Other Developments

9 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* (Page No. – 277)
9.1 Alkermes, Inc.
9.2 Bespak Europe, Ltd. (Subsidiary Of Consort Medical, Plc)
9.3 Crossject
9.4 Gerresheimer AG
9.5 Haselmeier Gmbh
9.6 Injex Pharma Gmbh (Subsidiary Of Hns International, Inc.)
9.7 Novo Nordisk A/S
9.8 Owen Mumford, Ltd.
9.9 Sanofi
9.10 Schott AG
9.11 Vetter Pharma-Fertigung Gmbh & Co. KG
9.12 Ypsomed Holding AG
*Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.

List Of Tables (143 Tables)

Table 1 Europe Injectable Drug Delivery Technologies Market, By Segment, 2010 - 2017 ($Million)
Table 2 Europe Injectable Drug Delivery Technologies Market, By Segment, 2010 - 2017 ($Million)
Table 3 Injection Drug Delivery Technologies Market, By Geography, 2010 - 2017 ($Million)
Table 4 Europe Injectable Drug Delivery Devices Technologies Market, By Product, 2010 - 2017 ($Million)
Table 5 Injection Drug Delivery Devices Technologies Market, By Geography, 2010 - 2017 ($Million)
Table 6 Conventional Injection Devices Market, By Geography, 2010 - 2017 ($Million)
Table 7 European Conventional Injection Devices Market, By Usability, 2010 - 2017 ($Million)
Table 8 Disposable Conventional Devices Market, By Geography, 2010 - 2017 ($Million)
Table 9 Reusable Conventional Devices Market, By Geography, 2010 - 2017 ($Million)
Table 10 European Conventional Injection Devices Market, By Material, 2010 - 2017 ($Million)
Table 11 Conventional Injection Devices (Glass) Market, By Geography, 2010 - 2017 ($Million)
Table 12 Conventional Injection Devices (Plastic) Market, By Geography, 2010 - 2017 ($Million)
Table 13 European Conventional Injection Devices Market, By Product, 2010 - 2017 ($Million)
Table 14 Fillable Conventional Injection Devices Market, By Geography, 2010 - 2017 ($Million)
Table 15 Prefilled Conventional Injection Devices Market, By Geography, 2010 - 2017 ($Million)
Table 16 Major Therapeutic Areas For Self-Injection Devices
Table 17 Europe Self-Injection Devices Market, By Product, 2010 - 2017 ($Million)
Table 18 Self-Injection Devices Market, By Geography, 2010 - 2017 ($Million)
Table 19 Pen Injector Market, By Geography, 2010 - 2017 ($Million)
Table 20 European Pen Injectors Market, By Product, 2010 - 2017 ($Million)
Table 21 Single Chamber Pen Injector Market, By Geography, 2010 - 2017 ($Million)
Table 22 Dual Chamber Pen Injector Market, By Geography, 2010 - 2017 ($Million)
Table 23 European Pen Injectors Market, By Usability, 2010 - 2017 ($Million)
Table 24 Disposable Pen Injectors Market, By Geography, 2010 - 2017 ($Million)
Table 25 Reusable Pen Injectors Market, By Geography, 2010 - 2017 ($Million)
Table 26 European Pen Injectors Market, By Design, 2010 - 2017 ($Million)
Table 27 Standard Pen Injectors Market, By Geography, 2010 - 2017 ($Million)
Table 28 Customized Pen Injectors Market, By Geography, 2010 - 2017 ($Million)
Table 29 Needle Free Injectors Market, By Geography, 2010 - 2017 ($Million)
Table 30 European Needle Free Injectors Market, By Product, 2010 - 2017 ($Million)
Table 31 Prefilled Needle Free Injectors Market, By Geography, 2010 - 2017 ($Million)
Table 32 Fillable Needle Free Injectors Market, By Geography, 2010 - 2017 ($Million)
Table 33 European Needle Free Injectors Market, By Technology, 2010 - 2017 ($Million)
Table 34 Jet-Based Needle Free Injector Market, By Geography, 2010 - 2017 ($Million)
Table 35 Spring-Based Needle Free Injector Market, By Geography, 2010 - 2017 ($Million)
Table 36 Laser-Powered Needle Free Injector Market, By Geography, 2010 - 2017 ($Million)
Table 37 Vibration-Based Needle Free Injector Market, By Geography, 2010 - 2017 ($Million)
Table 38 Europe Needle Free Injectors Market, By Usability, 2010 - 2017 ($Million)
Table 39 Disposable Needle Free Injectors Market, By Geography, 2010 - 2017 ($Million)
Table 40 Reusable Needle Free Injectors Market, By Geography, 2010 - 2017 ($Million)
Table 41 Auto Injectors Products Market, By Geography, 2010 - 2017 ($Million)
Table 42 Europe Auto Injectors Market, By Product, 2010 - 2017 ($Million)
Table 43 Prefilled Auto Injectors Market, By Geography, 2010 - 2017 ($Million)
Table 44 Fillable Auto Injectors Market, By Geography, 2010 - 2017 ($Million)
Table 45 Europe Auto Injectors Market, By Technology, 2010 - 2017 ($Million)
Table 46 Automated Auto Injectors Market, By Geography, 2010 - 2017 ($Million)
Table 47 Manual Auto Injectors Market, By Geography, 2010 - 2017 ($Million)
Table 48 Europe Auto Injectors Market, By Design, 2010 - 2017 ($Million)
Table 49 Standardized Auto Injectors Market, By Geography,2010 - 2017 ($Million)
Table 50 Customized Auto Injectors Auto Injectors Market, By Geography, 2010 - 2017 ($Million)
Table 51 Europe Auto Injectors Market, By Usability, 2010 - 2017 ($Million)
Table 52 Disposable Auto Injectors Market, By Geography, 2010 - 2017 ($Million)
Table 53 Reusable Auto Injectors Market, By Geography, 2010 - 2017 ($Million)
Table 54 Others Injectors Market, By Geography, 2010 - 2017 ($Million)
Table 55 Europe Injectable Drug Delivery Formulation Technologies Market, By Segment, 2010 - 2017 ($Million)
Table 56 Injectable Drug Delivery Formulation Technologies Market, By Geography, 2010 - 2017 ($Million)
Table 57 Europe Conventional Drug Delivery Formulation Technologies Market, 2010 - 2017 ($Million)
Table 58 Conventional Drug Delivery Formulation Technologies Market, By Geography, 2010 - 2017 ($Million)
Table 59 Injectable Solutions Conventional Drug Delivery Formulation Market, By Geography, 2010 - 2017 ($Million)
Table 60 Reconstituted/Lyophilized Conventional Drug Delivery Formulation Market, By Geography, 2010 - 2017 ($Million)
Table 61 Novel Drug Delivery Formulation Technologies Market, 2010 - 2017 ($Million)
Table 62 Novel Drug Delivery Formulation Technologies Market, By Geography, 2010 - 2017 ($Million)
Table 63 Liposome Drug Delivery Formulation Market, By Geography, 2010 - 2017 ($Million)
Table 64 Microspheres Drug Delivey Formulation Market, By Geography, 2010 - 2017 ($Million)
Table 65 Nanoparticles Drug Delivey Formulation Market, By Geography, 2010 - 2017 ($Million)
Table 66 Polymeric Micelles Drug Delivey Formulation Market, By Geography, 2010 - 2017 ($Million)
Table 67 Other Novel Drug Delivey Formulation Market, By Geography, 2010 - 2017 ($Million)
Table 68 Europe Injectable Drug Delivery Technologies Market, By Therapeutic Application, 2010 - 2017 ($Million)
Table 69 Europeauto-Immune Therapeutic Market, By Indication, 2010 - 2017 ($Million)
Table 70 Auto-Immune Therapeutic Market,By Geography, 2010 - 2017 ($Million)
Table 71 Multiple Sclerosis Market, By Geography, 2010 - 2017 ($Million)
Table 72 Rheumatoid Arthritis Market, By Geography, 2010 - 2017 ($Million)
Table 73 Crohn's Diseases Market, By Geography, 2010 - 2017 ($Million)
Table 74 Psoriasis Market, By Geography, 2010 - 2017 ($Million)
Table 75 Other Auto-Immune Diseases Market, By Geography, 2010 - 2017 ($Million)
Table 76 Europe Hormonal Disorders, By Indication, 2010 - 2017 ($Million)
Table 77 Hormonal Disorders Market, By Geography, 2010 - 2017($Million)
Table 78 Diabetes Market, By Geography, 2010 - 2017 ($Million)
Table 79 Anemia Market, By Geography, 2010 - 2017 ($Million)
Table 80 Reproductive Health Diseases Market, By Geography,2010 - 2017($Million)
Table 81 Antithrombotic Therapy Market, By Geography, 2010 - 2017 ($Million)
Table 82 Osteoporosis Market, By Geography, 2010 - 2017 ($Million)
Table 83 Growth Hormone Deficiency Market, By Geography, 2010 - 2017 ($Million)
Table 84 Orphan/Rare Diseases Therapeutic Market, By Geography, 2010 - 2017 ($Million)
Table 85 Oncology Therapeutic Market, By Geography, 2010 - 2017 ($Million)
Table 86 European Other Therapeutic Market, 2010 - 2017 ($Million)
Table 87 Other Therapeutic Market, By Geography, 2010 - 2017 ($Million)
Table 88 Pain Management Market, By Geography, 2010 - 2017 ($Million)
Table 89 Hepatitis C Market, By Geography, 2010 - 2017 ($Million)
Table 90 Allergies/Anaphylytic Shock Market, By Geography, 2010 - 2017 ($Million)
Table 91 Aesthetic Treatment Market, By Geography, 2010 - 2017 ($Million)
Table 92 Germany: Injectable Drug Delivery Technologies Market, 2010 - 2017 ($Million)
Table 93 Germany: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 - 2017 ($Million)
Table 94 Germany: Injectable Drug Delivery Formulation Technologies Market, 2010 - 2017 ($Million)
Table 95 Germany: Injectable Drug Delivery Technologies Market, By Therapeutic Application, 2010 - 2017 ($Million)
Table 96 France: Injectable Drug Delivery Technologies Market, 2010 - 2017 ($Million)
Table 97 France: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 - 2017 ($Million)
Table 98 France: Injectable Drug Delivery Formulation Technologies Market, 2010 - 2017 ($Million)
Table 99 France: Injectable Drug Delivery Technologies Market, By Therapeutic Application 2010 - 2017 ($Million)
Table 100 U.K.: Injectable Drug Delivery Technologies Market, 2010 - 2017 ($Million)
Table 101 U.K.: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 - 2017 ($Million)
Table 102 U.K.: Injectable Drug Delivery Formulation Technologies Market, 2010 - 2017 ($Million)
Table 103 U.K.: Injectable Drug Delivery Technologies Market, By Therapeutic Application 2010 - 2017 ($Million)
Table 104 Spain: Injectable Drug Delivery Technologies Market, 2010 - 2017 ($Million)
Table 105 Spain: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 - 2017 ($Million)
Table 106 Spain: Injectable Drug Delivery Formulation Technologies Market, 2010 - 2017 ($Million)
Table 107 Spain: Injectable Drug Delivery Technologies Market, By Therapeutic Application 2010 - 2017 ($Million)
Table 108 Italy: Injectable Drug Delivery Technologies Market, 2010 - 2017 ($Million)
Table 109 Italy: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 - 2017 ($Million)
Table 110 Italy: Injectable Drug Delivery Formulation Technologies Market, 2010 - 2017 ($Million)
Table 111 Italy: Injectable Drug Delivery Technologies Market, By Therapeutic Application 2010 - 2017 ($Million)
Table 112 Russia: Injectable Drug Delivery Technologies Market, 2010 - 2017 ($Million)
Table 113 Russia: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 - 2017 ($Million)
Table 114 Russia: Injectable Drug Delivery Formulation Technologies Market, 2010 - 2017 ($Million)
Table 115 Russia: Injectable Drug Delivery Technologies Market, By Therapeutic Application 2010 - 2017 ($Million)
Table 116 ROE: Injectable Drug Delivery Technologies Market, 2010 - 2017 ($Million)
Table 117 ROE: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 - 2017 ($Million)
Table 118 ROE: Injectable Drug Delivery Formulation Technologies Market, 2010 - 2017 ($Million)
Table 119 ROE: Injectable Drug Delivery Technologies Market, By Therapeutic Application 2010 - 2017 ($Million)
Table 120 Expansion, 2010 - 2013
Table 121 Agreements, Partnerships, Collaborations & Joint Ventures, 2010 - 2013
Table 122 New Product Launch, 2010 - 2013
Table 123 Mergers & Acquisitions, 2010 - 2013
Table 124 Other Developments, 2010 - 2013
Table 125 Alkermes: Total Revenue And R&D Expenses, 2009 - 2011 ($Million)
Table 126 Alkermes: Total Revenue, By Geography, 2009 - 2011 ($Million)
Table 127 Consort Medical: Total Revenue And R&D Expense, 2009 - 2011 ($Million)
Table 128 Consort Medical: Total Revenue, By Geography, 2009 - 2011 ($Million)
Table 129 Gerresheimer Ag: Total Revenue And R&D Expenses, 2010 - 2012 ($Million)
Table 130 Gerresheimer Ag: Total Revenue, By Segment, 2010 - 2012 ($Million)
Table 131 Gerresheimer Ag: Total Revenue, By Geography, 2010 - 2012 ($Million)
Table 132 Novo Nordisk: Total Revenue And R&D Expenses, 2010 - 2012 ($Billion)
Table 133 Novo Nordisk: Total Revenue, By Segment, 2010 - 2012 ($Billion)
Table 134 Novo Nordisk: Total Revenue, By Geography, 2010 - 2012 ($Billion)
Table 135 Sanofi: Total Revenue & R&D Expenditure, 2010 - 2012 ($Billion)
Table 136 Sanofi: Total Revenue, By Segment, 2010 - 2012 ($Billion)
Table 137 Sanofi: Total Revenue, By Geography, 2010 - 2012 ($Billion)
Table 138 Schott Ag: Total Revenue And R&D Expenditures, 2010 - 2012 ($Million)
Table 139 Schott Ag: Total Revenue, By Geography, 2010 - 2012 ($Million)
Table 140 Ypsomed: Total Revenue And R&D Expenses, 2009 - 2011 ($Million)
Table 141 Ypsomed: Total Revenue, By Segment, 2009 - 2011 ($Million)
Table 142 Ypsomed: Total Revenue, By Geography, 2009 ($Million)
Table 143 Ypsomed: Total Revenue, By Geography, 2010 - 2011 ($Million)


List Of Figures (26 Figures)

Figure 1 Europe Injectable Drug Delivery Technologies Market, By Segment, 2012 & 2017
Figure 2 Injectable Drug Delivery Technologies Market, By Geography, 2012
Figure 3 Injectable Drug Delivery Technologies Market Segmentation
Figure 4 Injectable Drug Delivery Technologies Market Segmentation
Figure 5 Market Segmentation Of Injectable Drug Delivery Technologies, By Therapeutic Application
Figure 6 Injectable Drug Delivery Technologies Market Dynamics
Figure 7 Europeconventional Injection Devices Market, By Key Players, 2012 ($Million)
Figure 8 European Pen Injectors Market, By Key Players, 2012 ($Million)
Figure 9 Injectable Drug Delivery Devices Technologies Market Segmentation
Figure 10 Factors Affecting Selection Of An Injectable Device
Figure 11 European Self-Injection Devices Market, By Product, 2010 - 2017 ($Million)
Figure 12 Self-Injection Devices Market Segmentation
Figure 13 Factors Affecting Selection Of Self-Injection Device
Figure 14 Conventional Drug Delivery Formulation Technologies Market Segmentation
Figure 15 Europe Novel Drug Delivey Formulation Market, 2012 & 2017 ($Million)
Figure 16 Novel Drug Delivery Formulation Technologies Segmentation
Figure 17 Europe Injectable Drug Delivery Technologies Market, By Therapeutic Application, 2010 - 2017 ($Million)
Figure 18 Injectable Drug Delivery Technologies Market Segmentation, By Therapeutic Applications
Figure 19 Auto-Immune Therapeutic Market Segmentation
Figure 20 Hormonal Disorders Market Segmentation
Figure 21 Key Growth Strategies, 2010 - 2013
Figure 22 Key Growth Strategies, By Companies, 2010 - 2013
Figure 23 Geographical Expansions, By Company, 2010 - 2013
Figure 24 Agreements, Partnerships, Collaborations & Joint Ventures, By Company, 2010 - 2013
Figure 25 New Product Launch, By Company, 2010 - 2013
Figure 26 Mergers & Acquisitions, By Company, 2010 - 2013

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界の注入型ドラッグデリバリー(薬物送達)市場]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆